Regulatory Post Marketing Commitment Plan
Showing 1 - 25 of >10,000
Amlodipine/Atorvastatin Drug Use Investigation
Completed
- Hypertension
- +3 more
- (no location specified)
Jan 26, 2021
Long Term Use Of Lyrica
Completed
- Neuropathic Pain
- Pregabalin (Lyrica) capsule
- (no location specified)
Jan 15, 2021
Pregabalin for Fibromyalgia
Completed
- Pain Associated With Fibromyalgia
- (no location specified)
Jan 15, 2021
Maraviroc In Patients For HIV Patients
Completed
- CCR5-tropic HIV-1 Infection
- CELSENTRI® Tablets
- (no location specified)
Dec 6, 2019
Crizotinib (Regulatory Post Marketing Commitment Plan)
Completed
- Non-small Cell Lung Cancer
- Crizotinib (Xalkori)
- (no location specified)
Sep 12, 2019
Xolair® for Chronic Rhinosinusitis With Nasal Polyps
Recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- Xolair
-
Bundang Gu, Gyeonggi Do, Korea, Republic ofNovartis Investigative Site
Jan 19, 2023
Lucentis® in Patients With Retinopathy of Prematurity
Not yet recruiting
- Retinopathy of Prematurity
- Lucentis
- (no location specified)
Jun 28, 2022
'OLAP' (OLAparib Regulatory Post-marketing Surveillance)
Recruiting
- Ovarian Cancer
- +3 more
-
Busan, Korea, Republic of
- +17 more
Jan 9, 2023
Diphtheria, Tetanus, Pertussis Trial in Seoul (TETRAXIM™: Combined adsorbed diphtheria, tetanus, acellular pertussis and
Completed
- Diphtheria
- +3 more
- TETRAXIM™: Combined adsorbed diphtheria, tetanus, acellular pertussis and enhanced inactivated polio
-
Seoul, Korea, Republic of(unnamed)
Mar 15, 2022
Herpes Zoster Subunit Vaccine During Pregnancy in Adult
Not yet recruiting
- Herpes Zoster
- Data collection
- (no location specified)
Mar 31, 2023
ELIQUIS Regulatory Post-Marketing Surveillance In Clinical
Completed
- Venous Thromboembolism
-
Shinjuku-ku, Tokyo, JapanLocal Institution
Feb 3, 2022
Safety And Efficacy Of Rifabutin In HIV Patients
Completed
- Non-tuberculous Mycobacterial Diseases
- +2 more
- (no location specified)
Jun 13, 2019
Regulatory Post-Marketing Surveillance Study for Brolucizumab
Recruiting
- Neovascular Age-related Macular Degeneration
- brolucizumab
-
Daegu, Dalseo Gu, Korea, Republic of
- +26 more
Jun 21, 2022
Vahelva Respimat Regulatory Post-marketing Surveillance in
Completed
- Pulmonary Disease, Chronic Obstructive
- Vahelva® Respimat® (Tiotropium + Olodaterol fixed dose combination)
-
One Or Multiple Sites, Korea, Republic ofChonnam National University Hospital
Feb 28, 2022
(PMS) in Korean Patients With Type 2 Diabetes Mellitus
Recruiting
- Diabetes Mellitus, Type 2
-
Cheonan-si, Cheonan-si, Chungcheongnam-do, Korea, Republic of
- +2 more
Jul 26, 2022